PRO-542

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePRO-542
Drug Alias NameCD4 IgG2PRO-542
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionHIV fusion inhibitorsAnti-CD4
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Progenics Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAcquired Immunodeficiency SyndromeHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A